Fremanezumab for preventing migraine

Supporting evidence

• Evaluation report

• Committee papers (TA764) (PDF 667 KB)

  Published:

  02 February 2022

• Appraisal consultation committee papers (TA631) (PDF 3.9 MB)

  Published:

  03 June 2020

• Final appraisal determination committee papers (TA631) (PDF 2.95 MB)

  Published:

  03 June 2020